Harvard Bioscience Inc is a developer, manufacturer and marketer of scientific instruments, systems and lab consumables used to advance life science for basic research, drug discovery, clinical and environmental testing.
Harvard Bioscience Introduces Next Generation Inhalation System to Aid in the Fight Against COVID-19
Mar 23, 2020 @ 13:00
Harvard Bioscience, Inc. (HBIO) has launched an innovative technology – known as Accumulated Inhaled Aerosol (AIA) – for academic researchers, contract research organizations (CROs) and pharmaceutical companies involved in pre-clinical inhalation and exposure studies. You can identify these statements...
HOLLISTON, Mass., Feb. 26, 2020 -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the three and twelve months ended December 31,....
NEW YORK, NY / ACCESSWIRE / February 26, 2020 / Harvard Bioscience, Inc. (NASDAQ:HBIO) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on February 26, 2020 ......
Harvard Bioscience Schedules Fourth Quarter 2019 Earnings Conference Call for February 26, 2020 at 8:00 AM ET
Feb 11, 2020 @ 22:15
HOLLISTON, Mass., Feb. 11, 2020 -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for fourth quarter ended December 31, 2019 before the market....